Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Linda Messick v. Novartis Pharmaceuticals Corp.
Case Number:
13-15433
Court:
Nature of Suit:
3365 Personal Injury-Product Liability
Companies
Sectors & Industries:
-
April 04, 2014
9th Circ. Allows Expert Testimony In Novartis Jaw Injury Row
The Ninth Circuit on Friday overturned a lower court's order barring an expert from testifying that Novartis Pharmaceuticals Corp.'s bone drugs Aredia and Zometa caused a user to sustain jaw injuries, ruling that the doctor's testimony was not unreliable or irrelevant.
-
February 04, 2014
9th Circ. Urged To Reinstate Expert In Novartis Jaw Injury Suit
Two former users of Novartis Pharmaceuticals Corp. bone drugs Aredia and Zometa urged the Ninth Circuit on Monday to allow expert testimony that the medications caused their jaw injuries and to revive their lawsuits against the drugmaker.